000 01494 a2200445 4500
005 20250516113632.0
264 0 _c20130308
008 201303s 0 0 eng d
022 _a1539-6304
024 7 _a10.2500/aap.2012.33.3597
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBewtra, Againdra K
245 0 0 _aC1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
_h[electronic resource]
260 _bAllergy and asthma proceedings
_c
300 _a427-31 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAngioedemas, Hereditary
_xdrug therapy
650 0 4 _aChild
650 0 4 _aComplement C1 Inhibitor Protein
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMental Health
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aQuality of Life
650 0 4 _aSurveys and Questionnaires
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aLevy, Robyn J
700 1 _aJacobson, Kraig W
700 1 _aWasserman, Richard L
700 1 _aMachnig, Thomas
700 1 _aCraig, Timothy J
773 0 _tAllergy and asthma proceedings
_gvol. 33
_gno. 5
_gp. 427-31
856 4 0 _uhttps://doi.org/10.2500/aap.2012.33.3597
_zAvailable from publisher's website
999 _c22148821
_d22148821